Seok‐Young Kim

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of <i>EGFR</i> Exon 20 Insertion–Driven NSCLC

Jiyeon Yun, Soo‐Hwan Lee, Seok‐Young Kim et al. · Cancer Discovery · 2020 · 272 citations · Full text

The ribonuclease activity of SAMHD1 is required for HIV-1 restriction

Jeongmin Ryoo, Jongsu Choi, Changhoon Oh et al. · Nature Medicine · 2014 · 267 citations · Full text

Viral Replication, Hiv-1 Restriction, Human Retrovirus +8

Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma

Seok‐Young Kim, Sang-Min Kim, Su-Min Lim et al. · Clinical Cancer Research · 2021 · 143 citations · Full text

YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non–Small Cell Lung Cancer

Jiyeon Yun, Min Hee Hong, Seok‐Young Kim et al. · Clinical Cancer Research · 2019 · 124 citations · Full text

Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front–Mutant ROS1-Rearranged Non–Small Cell Lung Cancer

Mi Ran Yun, Dong Hwi Kim, Seok‐Young Kim et al. · Clinical Cancer Research · 2020 · 115 citations · Full text